Yellow Fever Vaccines Now Accessible To Lira Residents Through The Public Sector After a Decade

After a decade of not accessing Yellow fever vaccines through the Public sector, residents of Lira district are excited about a new delivery made by the Ministry of Health.  On January 7th, 2023, the Ministry delivered 412,320 doses of Yellow Fever Vaccines. The district last conducted yellow vaccination in 2010.  The vaccines will be used during the…

The Netherlands helps Masaka city set up a modern mortuary

 St Joseph Catholic Missionary Hospital Kitovu, in Masaka City, has set up a modern mortuary. The mortuary worth UGX 277 million Shillings was constructed through a partnership with the Make People Stronger Foundation based in the Netherlands. Doctor Alfred Lumala, the Hospital Administrator says that the new mortuary is equipped with 32 compartments, fitted with…

Managing emotions better could prevent pathological ageing

Negative emotions, anxiety and depression are thought to promote the onset of neurodegenerative diseases and dementia. But what is their impact on the brain and can their deleterious effects be limited?  Neuroscientists at the University of Geneva (UNIGE) observed the activation of the brains of young and older adults when confronted with the psychological suffering of others.   The…

How Rwanda is Using Artificial Intelligence to Improve Healthcare

An innovation that is addressing procurement constraints is making drug stock-outs and shortage of medical equipment in health facilities in Rwanda a thing of the past.  Viebeg Technologies, a venture capital-backed Health Tech company, is helping to expand access to affordable health care in Central and East Africa by aiding healthcare facilities in procuring supplies…

A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis

A new all-oral, six-month treatment regimen is safer and more effective at treating multidrug-resistant tuberculosis (MDR-TB) than the current options, according to results of a Doctors Without Borders/Médecins Sans Frontières (MSF) study published in the New England Journal of Medicine today. These findings come from MSF’s TB PRACTECAL, the first-ever multi-country, randomized, controlled clinical trial to…

Panoramic Trial Finds Molnupiravir Does Not Reduce Hospitalisation

Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with…